Galanin System in Human Glioma and Pituitary Adenoma.
Falkenstetter, S; Leitner, J; Brunner, SM; Rieder, TN; Kofler, B; Weis, S;
Front Endocrinol (Lausanne). 2020; 11: 155
Full papers/articles (Journal)

Validation of antibody-based tools for galanin research.
Brunner, SM; Koller, A; Stockinger, J; Locker, F; Leis, S; Ernst, F; Strasser, P; Brodowicz, B; Ebner, S; Holub, BS; Rauch, I; Graf, K; Lang, R; Kofler, B;
Peptides. 2019; 120: 170009
Full papers/articles (Journal)

GAL3 receptor knockout mice exhibit an alcohol-preferring phenotype
Genders, SG; Scheller, KJ; Jaehne, EJ; Turner, BJ; Lawrence, AJ; Brunner, SM; Kofler, B; van den Buuse, M; Djouma, E;
Addict Biol. 2019; 24(5): 886-897.
Full papers/articles (Journal)

Influence of the regulatory peptide galanin on cytokine expression in human monocytes.
Ramspacher, A; Neudert, M; Koller, A; Schlager, S; Kofler, B; Brunner, SM;
Ann N Y Acad Sci. 2019; 1455(1): 185-195.
Full papers/articles (Journal)

Lack of Galanin Receptor 3 Alleviates Psoriasis by Altering Vascularization, Immune Cell Infiltration, and Cytokine Expression.
Locker, F; Vidali, S; Holub, BS; Stockinger, J; Brunner, SM; Ebner, S; Koller, A; Trost, A; Reitsamer, HA; Schwarzenbacher, D; Lang, R; Kofler, B;
J Invest Dermatol. 2018; 138(1):199-207
Full papers/articles (Journal)

In vitro toxicity of the galanin receptor 3 antagonist SNAP 37889.
Koller, A; Rid, R; Beyreis, M; Bianchini, R; Holub, BS; Lang, A; Locker, F; Brodowicz, B; Velickovic, O; Jakab, M; Kerschbaum, H; Önder, K; Kofler, B;
Neuropeptides. 2016; 56:83-88
Full papers/articles (Journal)

Pharmacological stimulation of GAL1R but not GAL2R attenuates kainic acid-induced neuronal cell death in the rat hippocampus.
Webling, K; Groves-Chapman, JL; Runesson, J; Saar, I; Lang, A; Sillard, R; Jakovenko, E; Kofler, B; Holmes, PV; Langel, Ü;
Neuropeptides. 2016; 58: 83-92.
Full papers/articles (Journal)

Ala(5)-galanin (2-11) is a GAL2R specific galanin analogue.
Webling, K; Runesson, J; Lang, A; Saar, I; Kofler, B; Langel, Ü;
Neuropeptides. 2016; 60:75-82
Full papers/articles (Journal)

Physiology, signaling, and pharmacology of galanin peptides and receptors: three decades of emerging diversity.
Lang, R; Gundlach, AL; Holmes, FE; Hobson, SA; Wynick, D; Hökfelt, T; Kofler, B;
Pharmacol Rev. 2015; 67(1): 118-175.
Full papers/articles (Journal)

Galanin modulates human and murine neutrophil activation in vitro.
Locker, F; Lang, AA; Koller, A; Lang, R; Bianchini, R; Kofler, B;
Acta Physiol (Oxf). 2015; 213(3):595-602
Full papers/articles (Journal)

GAL3 receptor KO mice exhibit an anxiety-like phenotype.
Brunner, SM; Farzi, A; Locker, F; Holub, BS; Drexel, M; Reichmann, F; Lang, AA; Mayr, JA; Vilches, JJ; Navarro, X; Lang, R; Sperk, G; Holzer, P; Kofler, B;
Proc Natl Acad Sci U S A. 2014; 111(19):7138-7143
Full papers/articles (Journal)

Galanin is a modulator of eccrine sweat gland secretion.
Bovell, DL; Holub, BS; Odusanwo, O; Brodowicz, B; Rauch, I; Kofler, B; Lang, R;
Exp Dermatol. 2013; 22(2):141-143
Letters

The galanin peptide family in inflammation.
Lang, R; Kofler, B;
NEUROPEPTIDES. 2011; 45(1): 1-8.
Reviews

Galanin family of peptides in skin function.
Bauer, JW; Lang, R; Jakab, M; Kofler, B;
CELL MOL LIFE SCI. 2008; 65(12): 1820-1825.
Reviews

The galanin peptide family: Receptor phan-nacology, pleiotropic biological actions, and implications in health and disease
Lang, R; Gundlach, AL; Kofler, B
PHARMACOL THERAPEUT. 2007; 115(2): 177-207.
Reviews

Alarin is a vasoactive peptide
Santic, R; Schmidhuber, SM; Lang, R; Rauch, I; Voglas, E; Eberhard, N; Bauer, JW; Brain, SD; Kofler, B
P NATL ACAD SCI USA. 2007; 104(24): 10217-10222.
Full papers/articles (Journal)

Galanin and galanin receptors in human cancers.
Berger, A; Santic, R; Hauser-Kronberger, C; Schilling, FH; Kogner, P; Ratschek, M; Gamper, A; Jones, N; Sperl, W; Kofler, B;
NEUROPEPTIDES. 2005; 39(3): 353-359.
Reviews

Pharmacological and functional characterization of galanin-like peptide fragments as potent galanin receptor agonists.
Lang, R; Berger, A; Santic, R; Geisberger, R; Hermann, A; Herzog, H; Kofler, B;
NEUROPEPTIDES. 2005; 39(3): 179-184.
Full papers/articles (Journal)

Galanin receptor subtype GalR2 mediates apoptosis in SH-SY5Y neuroblastoma cells.
Berger, A; Lang, R; Moritz, K; Santic, R; Hermann, A; Sperl, W; Kofler, B;
ENDOCRINOLOGY. 2004; 145(2): 500-507.
Full papers/articles (Journal)

Galanin and galanin receptors in human gliomas
Berger, A; Santic, R; Almer, D; Hauser-Kronberger, C; Huemer, M; Humpel, C; Stockhammer, G; Sperl, W; Kofler, B
ACTA NEUROPATHOL. 2003; 105(6): 555-560.
Full papers/articles (Journal)

Elevated expression of galanin receptors in childhood neuroblastic tumors.
Berger, A; Tuechler, C; Almer, D; Kogner, P; Ratschek, M; Kerbl, R; Iismaa, TP; Jones, N; Sperl, W; Kofler, B;
NEUROENDOCRINOLOGY. 2002; 75(2): 130-138.
Full papers/articles (Journal)

Biphasic response to human galanin of extracellular acidification in human Bowes melanoma cells.
Lang, R; Berger, A; Hermann, A; Kofler, B;
Eur J Pharmacol. 2001; 423(2-3): 135-141.
Full papers/articles (Journal)